CNBC
@cnbc
This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit https://t.co/FKs5eW6uxk
10

Cookies allow you to use this website normally and customize your experience on this website.

>>More information